Stay updated on DARWINII Clinical Trial

Sign up to get notified when there's something new on the DARWINII Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DARWINII Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    DARWIN II's study status updated to Completed with primary completion and study completion dates now listed as 2025-11-30, while enrollment remains at 50. Drug labeling/details were clarified (Atezolizumab/MPDL3280A) and administrative items such as the IPD sharing plan and U.S. manufacturing notes were removed to reflect the finalized study record.
    Difference
    1%
    Check dated 2026-05-08T12:36:29.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page’s revision/version marker was updated from v3.5.2 to v3.5.3, indicating a site template or release update rather than a change to the study record content.
    Difference
    0.0%
    Check dated 2026-04-24T06:29:41.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Page version updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:48:45.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0. No changes to study content, eligibility criteria, or outcome data are indicated by this update.
    Difference
    0.0%
    Check dated 2026-03-19T06:18:09.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T02:46:06.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed; older funding/operating-status notices have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:30:33.000Z thumbnail image

Stay in the know with updates to DARWINII Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DARWINII Clinical Trial page.